Stocks
Clover Health Investments (CLOV) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -38.7% | -23.0% | -16.5% | -3.28% | -4.36% | -2.50% | ||
| Changes by years, y/y, % | -27pp | +16pp | +7pp | +13pp | -1pp | -17.9% | |||
Clover Health Investments. EBITDA margin, %
Clover Health Investments. EBITDA margin, changes, pp
Clover Health Investments (CLOV) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -0.17% | -2.13% | -4.83% | -10.0% | 3.72% | -2.50% | |
| Changes by years, y/y, % | +6pp | -4pp | -2pp | -4pp | +4pp | |||
| Changes by quarters, q/q, % | +6pp | -2pp | -3pp | -5pp | +14pp | |||
